ePrints

Guidelines on prescribing psychotropic medication during the perinatal period

Lookup NU author(s): Professor Hamish McAllister-WilliamsORCiD

Downloads

• Accepted version [.pdf]

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Mark Allen Group, 2019.

For re-use rights please refer to the publisher's terms and conditions.

Abstract

The use of psychotropic medication in pregnant and breastfeeding women is an area of great challenge for both women with mental health problems and clinicians. There are many uncertainties regarding risks of untreated illness to mother, fetus or infant as well as concerns over potential risks to the fetus or infant associated with use of psychotropic medications during pregnancy or breastfeeding. The purpose of the British Association of Psychopharmacology guidelines is to provide advice regarding making decisions around treating mental illness in the perinatal period. This article provides a summary and explanation of the consensus guidance.

Publication metadata

Author(s): Romaine E, McAllister-Williams RH

Publication type: Article

Publication status: Published

Journal: British Journal of Hospital Medicine

Year: 2019

Volume: 80

Issue: 1

Pages: 27-32

Online publication date: 28/12/2018

Acceptance date: 02/04/2018

Date deposited: 27/02/2019

ISSN (print): 1750-8460

ISSN (electronic): 1759-7390

Publisher: Mark Allen Group

URL: https://doi.org/10.12968/hmed.2019.80.1.27

DOI: 10.12968/hmed.2019.80.1.27

PubMed id: 30592677

Altmetrics

Share